17-(PROP-2-ENOYLOXY)-3,6,9,12,15-PENTAOXAHEPTADECAN-1-YL PROP-2-ENOATE, 95%, 250mg

5-Hydroxy-2-methyl-1H-indole-3-carbaldehyde, 95+%, 1g

4-Methyltetrahydro-2H-pyran-4-amine hydrochloride, 95.0%, 1g

(R)-(-)-3-Hydroxytetrahydrofuran, 98.0%, 5g

4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-6-(TRIFLUOROMETHYL)-1H-INDOLE, 95.0%, 500mg

Isoquinoline-7-carboxylic acid, 95.0%, 25g

4-(N,N-Dimethylsulfamoyl)benzoic acid, 95.0%, 2.5g

N-Cyclohexyl-p-toluenesulfonamide>99.0%(HPLC)(N)500g

1-BOC-3-(IODOETHYL)AZETIDINE, 95.0%, 250mg

7-Nitrooxindole, 95.0%, 250mg

Acétate de 3-méthoxy-3-méthylbutyle, min 98 %, pour la synthèse, 100 ml, emballage en verre

[4-Fluoro-3-(trifluoromethyl)phenyl](2,4,6-trimethoxyphenyl)iodonium p-Toluenesulfonate, >97.0%(HPLC), 250mg

1-(But-3-en-1-yl)piperazine, 95%, 250mg